Display Settings:

Format

Send to:

Choose Destination

    Bioorg Med Chem Lett. 2008 Nov 15;18(22):5941-4. Epub 2008 Sep 12.

    Recent progress with FKBP-derived destabilizing domains.

    Chu BW, Banaszynski LA, Chen LC, Wandless TJ.

    Department of Chemical and Systems Biology, Stanford University, 318 Campus Drive, Clark Center W350A, Stanford, CA 94305-5441, USA.

    The FKBP-derived destabilizing domains are increasingly being used to confer small molecule-dependent stability to many different proteins. The L106P domain confers instability to yellow fluorescent protein when it is fused to the N-terminus, the C-terminus, or spliced into the middle of yellow fluorescent protein, however multiple copies of L106P do not confer greater instability. These engineered destabilizing domains are not dominant to endogenous degrons that regulate protein stability.

    PMID: 18815033 [PubMed - indexed for MEDLINE]

    PMCID: 2593907

    Supplemental Content

    Click here to read Click here to read Click here to read

    Patient drug information

    • Tacrolimus (Prograf®)

      Tacrolimus is used along with other medications to prevent rejection (attack of a transplanted organ by the immune system of a person receiving the organ) in people who have received kidney, liver, or heart transplants. ...